Prize competition non-awardees

Evaluation of the Kidney Innovation Accelerator (KidneyX)

0990 Kidney X Attachment D - Non-Awardee Interview Guide_comments removed

Prize competition non-awardees

OMB: 0990-0471

Document [docx]
Download: docx | pdf

Form Approved

OMB No. 0990-XXXX

Exp. Date XX/XX/20XX











KidneyX Evaluation


Attachment D

KidneyX Interview Guide: Non-Awardee


















According to the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it displays a valid OMB control number. The valid OMB control number for this information collection is 0990-XXXX. The time required to complete this information collection is estimated to average 50 minutes per response, including the time to review instructions, search existing data resources, gather the data needed, to review and complete the information collection. If you have comments concerning the accuracy of the time estimate(s) or suggestions for improving this form, please write to: U.S. Department of Health & Human Services, OS/OCIO/PRA, 200 Independence Ave., S.W., Suite 336-E, Washington D.C. 20201, Attention: PRA Reports Clearance Officer.



Thank you for participating in this discussion. My name is [Interviewer Name]. I work for RTI, a research organization contracted by HHS to evaluate the Kidney Innovation Accelerator (KidneyX). The evaluation will assess the effects of KidneyX in terms of spurring innovative solutions to address kidney disease and improve outcomes for patients. The evaluation assesses participation in the prize competitions and potential longer-term outcomes related to commercialization of innovations.


The purpose of this interview is to get your perspectives as a [name of challenge] applicant.

Before we begin, I’d like to review a few key points about today’s discussion:

  • Your participation is voluntary, and you can decide not to respond to a question or to stop participating in the discussion at any time.

  • This conversation is one of several we will have to help inform the KidneyX evaluation.

  • The RTI IRB did not need to approve this study because our conversations will inform the program and there is little to no risk for participants.

  • You were selected as a key informant because you applied to the [name of challenge] and we’d like to understand more about your experience.

  • We have reserved 45 minutes for today’s discussion. So, I may have to interject at times to help us stay on topic, or to introduce a new topic. This will help us get through all the questions within the allotted time. We are happy to follow up with you on a later date if there are any topics we don’t get to today.

  • [Note taker], also from RTI, is on the line and will be taking high level notes. We would like to record the session so that we can have a full record of our conversation and accurate transcript. The recording and transcript will be stored on RTI’s secure project drive.


Do we have your permission to record?

  • Yes; If there is any point during the discussion that anyone would like for us to pause the recording, please just let us know.

  • No

Do you have any questions before we begin?


INTRODUCTIONS

  1. To start, can you please tell me a little bit about the nature of your involvement in the field of kidney health?

    • How long have you been involved in this field?

    • What are some of you or your organization’s contributions in this field?


MAIN QUESTIONS

Now I’d like to hear about your experiences around the KidneyX challenge application process.

  1. What led you to decide to submit an application to this round of KidneyX?

  • What information about KidneyX was important in your decision to submit an application?

  • What factors did you consider?

  • What did you anticipate would be the benefits of engaging with KidneyX?]

  1. To what extent were you satisfied with the application process?

    • What aspects of the process worked well/ not as well?

  • Information provided (e.g. clarity, completeness, timeliness)

  • Application process

  • Judging and feedback

  1. What (if any) challenges did you encounter in the application process?

    • In what ways could the process be improved?

  2. At the time you submitted your application, what what did you consider your probability of winning the prize? What factors did you think would make you more/or less likely to win?What factors made you hesitant to submit your application, if any?

  3. What is your next step in pursuing your submitted idea?

  4. Are you inclined to submit an application to a future KidneyX competition? Why or why not?

    • Would you recommend that other innovators interested in the kidney health domain participate in KidneyX? Why or why not?

  5. Thinking about the reasons you decided to submit an application, to what extent would you say your expectations have been met?


Now I’d like to hear about your experiences around the KidneyX challenge application process.

  1. Have there been any benefits to your organization of submitting an application, even though you were not selected for prize funding?

  2. How likely are you to apply for KidneyX prize funding again in the future?

    • What are reasons you would/would not apply?

  3. To what extent, if any, did submission of an application accelerate innovation in your [firm/organization], even though you did not receive prize funding?

    • In what ways?

  4. In what ways, if any, are you continuing to pursue development of your idea?

  5. In ways did your participation in KidneyX help you to be more successful or otherwise enhance your efforts?


SUMMARY AND WRAP UP

  1. Do you have any closing thoughts to share about the topics we discussed?

  2. Do you have any recommendations for KidneyX based on your experiences?


Thank you for your time and valuable feedback. Your input will help to inform the KidneyX evaluation.


File Typeapplication/vnd.openxmlformats-officedocument.wordprocessingml.document
AuthorHayes, Kim
File Modified0000-00-00
File Created2021-01-15

© 2024 OMB.report | Privacy Policy